- Starts: 16 February 2021
- Ends: 18 February 2021
- Website: Click to view
Almac Diagnostic Services is delighted to be exhibiting and speaking at Molecular Med Tri-Con (MMTC) 2021 on 16-18 February 2021.
Our speaker, Dr Katarina Wikstrom, will be discussing “Clinical Trial Assay & CDx Development in the era of Precision Medicine – Planning for Success.”
In this session, you will hear about:
- Regulatory considerations for assay development, validation & commercialisation.
- Choosing the right diagnostic partner: Experience, ability to deliver, transparency & trust.
- Biomarker led Clinical Trial Assay & Companion Diagnostic development & validation challenges.
- Case Study showcasing a recent Almac Biomarker Programme with a large Global Pharma partner.
Join us at this virtual event to discuss your needs. Should you need to contact our speaker directly please get in touch via email.
About Molecular Med Tri-Con (MMTC) 2021
Join international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics, vaccines and biotherapeutics, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence.
In addition to the leading research and technology presentations you have come to expect at the Tri-Con, now available for on-demand viewing, we have added interactive panel discussions and structured networking opportunities, for a comprehensive 3-day program designed to maximize collaboration and innovation… all without leaving your computer.